A phase II combination study of bortezomib with pegylated-liposomal doxorubicin in patients with ovarian cancer failing platinum containing regimens

被引：0
|
作者：
Scambia, G.
Parma, G.
Del Conte, G.
Hess, D.
Gadducci, A.
Katsaros, D.
Sessa, C.
Trudel, G. C.
Coceani, N.
Colombo, N.
机构：
[1] Univ Cattolica Sacro Cuore, Campobasso, Italy
[2] Ist Europeo Oncol, Milan, Italy
[3] Ist Nazl Tumori, I-20133 Milan, Italy
[4] Kantonsspital St Gallen, St Gallen, Switzerland
[5] Univ Pisa, Pisa, Italy
[6] Univ Turin, Turin, Italy
[7] Osped San Giovanni Bellinzona, Bellinzona, Switzerland
[8] Johnson & Johnson, Beerse, Belgium
[9] Sendo, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5581
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5581
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors
    Dees, E. Claire
    O'Neil, Bert H.
    Lindley, Celeste M.
    Collichio, Frances
    Carey, Lisa A.
    Collins, Jason
    Riordan, William J.
    Ivanova, Anastasia
    Esseltine, Dixie
    Orlowski, Robert Z.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 63 (01) : 99 - 107
  • [22] A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors
    E. Claire Dees
    Bert H. O’Neil
    Celeste M. Lindley
    Frances Collichio
    Lisa A. Carey
    Jason Collins
    William J. Riordan
    Anastasia Ivanova
    Dixie Esseltine
    Robert Z. Orlowski
    Cancer Chemotherapy and Pharmacology, 2008, 63 : 99 - 107
  • [23] Phase II Trial of Combination Therapy With Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Myeloma
    Jakubowiak, Andrzej J.
    Kendall, Tara
    Al-Zoubi, Ammar
    Khaled, Yasser
    Mineishi, Shin
    Ahmed, Asra
    Campagnaro, Erica
    Brozo, Christine
    Braun, Thomas
    Talpaz, Moshe
    Kaminski, Mark S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) : 5015 - 5022
  • [24] A phase I study of atrasentan in combination with liposomal doxorubicin in platinum resistant ovarian cancer
    Witteveen, PO
    Los, M
    Groenewegen, G
    Voest, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 233S - 233S
  • [25] A phase II study of the combination of liposomal doxorubicin (LD) and gemcitabine (G) in patients with relapsed ovarian cancer after chemotherapy containing platinum compounds.
    Gambino, A
    Tognon, G
    Galleri, G
    Agoni, L
    Pecorelli, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 492S - 492S
  • [26] Combination therapy with encapsulated liposomal doxorubicin and carboplatin in patients with platinum sensitive recurrent ovarian cancer - A national phase II study
    Vorobiof, Daniel A.
    Rapoport, Bernardo L.
    Slabber, Coenraad
    Eek, Richard
    Cohen, Graham
    Uys, Almarie
    ANNALS OF ONCOLOGY, 2004, 15 : 129 - 129
  • [27] A study of pegylated liposomal doxorubicin in platinum-refractory epithelial ovarian cancer
    Wilailak, S
    Linasmita, V
    ONCOLOGY, 2004, 67 (3-4) : 183 - 186
  • [28] A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin
    Mirza, Mansoor Raza
    Lund, Bente
    Lindegaard, Jacob Christian
    Keldsen, Nina
    Mellemgaard, Anders
    Christensen, Rene dePont
    Bertelsen, Kamma
    GYNECOLOGIC ONCOLOGY, 2010, 119 (01) : 26 - 31
  • [29] Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)
    Perez-Fidalgo, J. A.
    Cortes, A.
    Guerra, E.
    Garcia, Y.
    Iglesias, M.
    Sarmiento, U. Bohn
    Garcia, E. Calvo
    Sanchez, L. Manso
    Santaballa, A.
    Oaknin, A.
    Redondo, A.
    Rubio, M. J.
    Gonzalez-Martin, A.
    ESMO OPEN, 2021, 6 (04)
  • [30] The outcome of patients with platinum-resistant/refractory ovarian cancer treated with the combination of pegylated liposomal doxorubicin and gemcitabine
    Galic, V.
    Boulay, R.
    Thomas, M.
    Miller, R.
    Gillenwater, C.
    Chen, C.
    Martino, M.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S48 - S48
12345